Mepha Pharma AG - Irbesartan-HCT-Mepha 300mg/12.5mg, Filmtabletten | | 61497 | | 02 | | Irbesartan-HCT-Mepha 300mg/12.5mg | | Filmtabletten | | C09DA04 | | Irbesartan und Diuretika | | 08.02.2011 | | |
| Composition | irbesartanum 300.0 mg, hydrochlorothiazidum 12.5 mg, povidonum, amylum pregelificatum, poloxamerum 188, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.51 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 6000, macrogolum 400, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), pro compresso obducto. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Hydrochlorothiazide | 12.5 mg | Irbesartan | 300 mg |
| BAG: Principe actif | Concentr. |
---|
Hydrochlorothiazide | 12.5 mg | Irbesartan | 300 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
| | | | | | | | | | | | | | | | | | | | color. | | | color. | Hypromellosum | | Überzug | Macrogol | 400 | | | | | Poloxamer | 188 | | Povidone | | | | | | Silica Colloidalis Anhydrica | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
003 | 28 Comprimé(s) | 12.49 | 30.00 | B | LS | Non | 004 | 98 Comprimé(s) | 43.11 | 63.30 | B | LS | Non |
|
|